MedTrace Logo

Implants on Mobile Health Unit

NCT03347539 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2023-05-06

No results posted yet for this study

Summary

This study explores reasons why adolescents choose to receive a nexplanon implant and remove a Nexplanon implant. Nexplanon is provided as part of the standard of care on the University of Chicago mobile health unit. This study explores reasons for implantation and removal of Nexplanon on this mobile health unit.

Conditions

  • Contraception

Interventions

DEVICE

Nexplaon

This study is an exploratory study of user reasons for Nexplanon implant and removal, and NOT a study on the efficacy or safety of Nexplanon. Nexplanon has already been FDA approved and its efficacy and safety studied.

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Eligibility

Min Age
14 Years
Max Age
19 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-13
Primary Completion
2020-04-06
Completion
2020-04-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03347539 on ClinicalTrials.gov